Skip to main content
. 2007 Oct 24;65(1):3–11. doi: 10.1111/j.1365-2125.2007.03030.x

Figure 3.

Figure 3

Population pharmacokinetic profiles of rFVIIa during phases with and without liver circulation, for patients undergoing orthotopic liver transplantation, following a single dose of 80 μg kg−1 rFVIIa. Analysis of data from Planinsic et al.[17]. (Erichsen, Klitgaard, data on file 2004) No liver circulation, (—); Liver circulation, (––)